Insights into new-onset autoimmune diseases after COVID-19 vaccination
M Guo, X Liu, X Chen, Q Li - Autoimmunity reviews, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …
Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: a case report of pemphigus vulgaris and a literature review
E Calabria, F Canfora, M Mascolo, S Varricchio… - … -Research and Practice, 2022 - Elsevier
Background Cases of severe autoimmune blistering diseases (AIBDs) have recently been
reported in association with the severe acute respiratory syndrome coronavirus 2 (SARS …
reported in association with the severe acute respiratory syndrome coronavirus 2 (SARS …
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management
G Trivioli, A Marquez, D Martorana, M Tesi… - Nature Reviews …, 2022 - nature.com
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises
granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic …
granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic …
Autoimmune inflammatory rheumatic diseases post-COVID‐19 vaccination
A Safary, K Esalatmanesh, AT Eftekharsadat… - International …, 2022 - Elsevier
Vaccination against COVID-19 is one of the critical tools to provide herd immunity, reduce
mortality, and control the pandemic worldwide. Despite the safety of vaccination against …
mortality, and control the pandemic worldwide. Despite the safety of vaccination against …
Dual-positive MPO-and PR3-ANCA-associated vasculitis following SARS-CoV-2 mRNA booster vaccination: a case report and systematic review
E Baier, U Olgemöller, L Biggemann, C Buck, B Tampe - Vaccines, 2022 - mdpi.com
As the coronavirus disease 2019 (COVID-19) pandemic is ongoing, and new variants of
severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are emerging …
severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are emerging …
New-onset rheumatic immune-mediated inflammatory diseases following SARS-CoV-2 vaccinations until May 2023: a systematic review
A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking …
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking …
New onset of eosinophilic granulomatosis with polyangiitis following mRNA-based COVID-19 vaccine
E Nappi, M De Santis, G Paoletti, C Pelaia, F Terenghi… - Vaccines, 2022 - mdpi.com
Anti-SARS-CoV-2 vaccines are safe and effective, also in individuals with allergic and
immune-mediated diseases (IMDs). There are reports suggesting that vaccines may be able …
immune-mediated diseases (IMDs). There are reports suggesting that vaccines may be able …
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks
Introduction Since its emergence, there have been huge efforts to design vaccines against
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …
[HTML][HTML] Kidney injury associated with COVID-19 infection and vaccine: A narrative review
ICR Pacheco, DMN Costa, DS Sousa… - Frontiers in …, 2022 - frontiersin.org
The respiratory tract is the main infection site for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), resulting in many admissions to intensive care centers in …
coronavirus 2 (SARS-CoV-2), resulting in many admissions to intensive care centers in …
ANCA associated glomerulonephritis following SARS-CoV-2 vaccination: a case series and systematic review
T Thammathiwat, A Banjongjit, K Iampenkhae… - Vaccines, 2023 - mdpi.com
Vaccines against SARS-CoV-2 (COVID-19) proved beneficial for COVID-19 disease
attenuation and preventing virus spreading. Cumulative reports of the rarity of antineutrophil …
attenuation and preventing virus spreading. Cumulative reports of the rarity of antineutrophil …